Eptinezumab Demonstrated Migraine Preventive Efficacy on Day 1 After Dosing: Closed Testing Analysis from PROMISE-1 and PROMISE-2

Dodick, DW; Gottschalk, C; Tepper, SJ; Friedman, DI; Cady, R; Smith, J; Hirman, J; Snapinn, S

NEUROLOGY, 2020; 94 (15):